Lineage Cell Therapeutics, Inc. (LCTX)
1.725
+0.08
(+5.18%)
USD |
NYAM |
Apr 17, 13:56
Lineage Cell Therapeutics Market Cap : 429.68M for April 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| The Cooper Cos., Inc. | 13.71B |
| Pacira Biosciences, Inc. | 999.70M |
| OptimizeRx Corp. | 134.90M |
| Nutex Health, Inc. | 741.23M |
| Prime Medicine, Inc. | 695.13M |
Market Cap Related Metrics
| PS Ratio | 27.45 |
| PEG Ratio | -0.0332 |
| Price to Book Value | 9.645 |
| Price | 1.725 |
| Earnings Yield | -16.13% |
| PEGY Ratio | -0.0332 |